NCT04950712 - An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe. | Biotech Hunter

Enrollment

537

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

March 14, 2024

Study Completion Date

March 14, 2024

Conditions

Herpes Genitalis

Interventions

PROCEDURE

Blood sampling

Blood samples for HSV-2 testing and for HIV test are collected from patients at screening visit (first visit).

PROCEDURE

Anogenital lesion swab collection

Anogenital lesion swab of all lesions are collected at screening visit (only for newly infected HSV-2 patients) and at first genital HSV-2 recurrence during the study period.

Trial Locations (51)

19107

GSK Investigational Site, Philadelphia

20127

GSK Investigational Site, Milan

23235

GSK Investigational Site, Richmond

28010

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28922

GSK Investigational Site, Alcorcón

29600

GSK Investigational Site, Marbella

30067

GSK Investigational Site, Marietta

30082

GSK Investigational Site, Smyrna

31059

GSK Investigational Site, Toulouse

33011

GSK Investigational Site, Oviedo

33015

GSK Investigational Site, Miami

33126

GSK Investigational Site, Miami

33134

GSK Investigational Site, Miami

33317

GSK Investigational Site, Plantation

34295

GSK Investigational Site, Montpellier

38129

GSK Investigational Site, Memphis

42055

GSK Investigational Site, Saint-Etienne

43213

GSK Investigational Site, Columbus

44093

GSK Investigational Site, Nantes

46026

GSK Investigational Site, Valencia

63108

GSK Investigational Site, St Louis

64111

GSK Investigational Site, Kansas City

69495

GSK Investigational Site, Pierre-Bénite

70120

GSK Investigational Site, Bari

75010

GSK Investigational Site, Paris

75679

GSK Investigational Site, Paris

76104

GSK Investigational Site, Fort Worth

77054

GSK Investigational Site, Houston

77339

GSK Investigational Site, Houston

78705

GSK Investigational Site, Austin

90027

GSK Investigational Site, Los Angeles

90100

GSK Investigational Site, Oulu

90127

GSK Investigational Site, Palermo

90806

GSK Investigational Site, Long Beach

94102

GSK Investigational Site, San Francisco

02215

GSK Investigational Site, Boston

08648

GSK Investigational Site, Lawrenceville

07103

GSK Investigational Site, Newark

00250

GSK Investigational Site, Helsinki

FI-33100

GSK Investigational Site, Tampere

00144

GSK Investigational Site, Roma

08001

GSK Investigational Site, Barcelona

B4 6DH

GSK Investigational Site, Birmingham

BN2 1ES

GSK Investigational Site, Brighton

LS2 8NG

GSK Investigational Site, Leeds Yorkshire

L7 8YE

GSK Investigational Site, Liverpool

SE1 0UN

GSK Investigational Site, London

WC1E 6JB

GSK Investigational Site, London

SO14 0YG

GSK Investigational Site, Southampton